Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) – Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract
Awarded on September 15, 2025. Full description on SAM.gov.
Overview
- Posted
- September 16, 2025
- Notice type
- Award Notice
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Place of performance
- Silver Spring, Texas, 77598
- PSC
- AJ12: R&D- GENERAL SCIENCE/TECHNOLOGY: PHYSICAL SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Last updated
- Nov 8, 2026
- First published
- Last updated on SAM.gov
- Award date
- Sep 15, 2025
- Award amount (SAM.gov award notice)
- $50.0M
Identifiers
- Solicitation number
- 75F40124R00064
- Notice ID
- b5f18d924b64480295b9816059860a6e
- Award number (PIID)
- 75F40125D00003
Description
This is a commercial services Food and Drug Administration (FDA) open market single-award Indefinite Delivery-Indefinite Quantity (IDIQ) type contract set aside 100% for small business. The scope of activities FDA may require of the contractor shall include the capability to conduct multiple Phase I clinical trials within a year and at times in parallel, and the provision of a full range of services to support the clinical trials and reporting of the results. The Authorized Task Order (TO) type under this IDIQ contract is Firm-Fixed-Price (FFP).
Award Overview
Award Number
75F40125D00003
Award Amount (SAM.gov award notice)
$50.0M
Award Date
Sep 15, 2025
Awardee
Awardee UEI
FWWJT8QCEDY4
Awardee CAGE Code
9Z4C3
Awardee Address
Webster, TX 77598, UNITED STATES
Original Solicitation
Notice ID: b5f18d924b64480295b9816059860a6e
Posted Date: Sep 16, 2025
Original Response Deadline: Not specified
Task Orders Under This IDV
Top 10 by total obligated
- 75F40126F19005TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLCDepartment of Health and Human ServicesNAICS 541714$1.6MSigned Sep 22, 2026
- 75F40126F19004TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLCDepartment of Health and Human ServicesNAICS 541714$1.3MSigned Sep 21, 2026
- 75F40126F19001TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLCDepartment of Health and Human ServicesNAICS 541714$1.2MSigned Sep 29, 2026
More From This Vendor
Top 5 most recent
- 75F40126F19001TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLCDepartment of Health and Human ServicesNAICS 541714$1.2MSigned Sep 29, 2026
- 75F40126F19005TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLCDepartment of Health and Human ServicesNAICS 541714$1.6MSigned Sep 22, 2026
- 75F40126F19004TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLCDepartment of Health and Human ServicesNAICS 541714$1.3MSigned Sep 21, 2026
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
- 2Version 2Combined Synopsis/SolicitationArchived
Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) – Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract
- 5Version 5Award NoticeArchivedCurrent
Type changed from Combined Synopsis/Solicitation to Award Notice
Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) – Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract
Other notices for this solicitation
- Combined SynopsisJul 18, 2024
Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) – Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75F40124R00064
Archive Date
Sep 30, 2025
Office Address
Beltsville, MD, 20705